Intas Pharmaceuticals Overview
- Founded
-
1976

- Status
-
Private
- Employees
-
18,000

- Latest Deal Type
-
2ndary - Private
- (Announced)
- Financing Rounds
-
13
- Investments
-
1
Intas Pharmaceuticals General Information
Description
Operator of a global pharmaceutical company intended to offer biopharmaceutical products and services. The company specializes in oncology products for solid tumors, hematological malignancies and supportive therapies and also offers products for critical disorders. Its success and incessant growth lie in the clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades.
Contact Information
Website
www.intaspharma.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Primary Office
- Corporate House, Near Sola Bridge
- S. G. Highway, Thaltej
- Ahmedabad, Gujarat 380054
- India
+91 079 0000 0000
Intas Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Intas Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a global pharmaceutical company intended to offer biopharmaceutical products and services. The company speci
Pharmaceuticals
Ahmedabad, India
18,000
As of 2022
000.00
0.00
0000-00-00
00000000000
000.00
Intas Pharmaceuticals Competitors (38)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Glenmark Pharmaceuticals | Corporation | Mumbai, India | 00000 | 00000 | 000000000 | 00000 |
000000 | Formerly PE-Backed | Bangalore, India | 00000 | 000.00 | 00000000 | 000.00 |
00000 | Corporation | Mumbai, India | 00000 | 00000000 | ||
000000 000000 | Corporation | Mumbai, India | 0000 | |||
000000 00000000000 | Formerly VC-backed | Ardsley, NY | 000 | 00000 | 000000&0 |
Intas Pharmaceuticals Patents
Intas Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3799864-A1 | Essentially sodium-free effervescent solid pharmaceutical compositions | Pending | 02-Oct-2019 | 0000000000 | 0 |
EP-3833335-A1 | Pharmaceutical composition comprising hmg-coa reductase inhibitors and fenofibrate | Pending | 31-Jul-2019 | 00000000 | |
CA-3137265-A1 | A stable, ready to use aqueous pharmaceutical composition of pemetrexed | Pending | 01-May-2019 | 0000000000 | |
US-20210137917-A1 | Pharmaceutical composition of nintedanib esylate | Pending | 09-Apr-2018 | 0000000000 | |
EP-3773516-A1 | Pharmaceutical composition of nintedanib esylate | Pending | 09-Apr-2018 | A61K31/496 |
Intas Pharmaceuticals Executive Team (7)
Intas Pharmaceuticals Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
000000 0000000 | Intas Pharmaceuticals | Vice Chairman, Managing Director & Board Member | 000 0000 |
0000000 0000000 | Intas Pharmaceuticals | Founder & Board Member | 000 0000 |
000000 0000 | Intas Pharmaceuticals | Board Member | 000 0000 |
000000 0000000 | Intas Pharmaceuticals | Managing Director & Board Member | 000 0000 |
000000000 000000000 | Intas Pharmaceuticals | Board Member | 000 0000 |
Intas Pharmaceuticals Signals
Intas Pharmaceuticals Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Intas Pharmaceuticals Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000 0000 0000 | 04-Oct-2016 | 0000000000 | 00.000 | Biotechnology |